Applying Embryo‐Derived Immune Tolerance to the Treatment of Immune Disorders
- 27 September 2007
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1110 (1) , 602-618
Abstract
Pregnancy is a unique immune state in which both mother and embryo/fetus tolerate and interact with one another through term, without interfering with the mother's native immunity. When the embryo is viable, it initiates maternal immune tolerance (IT)—but not immune suppression. The balance is complex: some immune disorders are ameliorated during pregnancy, despite the presence of an “inflammatory” environment. We have identified a pregnancy viability biomarker—preimplantation factor (PIF)—secreted only by viable embryos, which helps to initiate this maternal tolerance and uterine receptivity. Using anti‐PIF antibodies, we have detected PIF in the fetus and placenta. Beyond enhancing uterine receptivity locally, PIF has also been detected in maternal circulation, and may promote peripheral tolerance. In the fetus, PIF may help avoid a “graft‐versus‐host”‐type reaction PIF exhibits unique potent immune‐modulatory effects and its synthetic analogue has been shown to exert significant protection in diverse immune scenarios. Nontoxic, low‐dose, short‐term PIF administration has led to long‐term effects in preclinical models of multiple sclerosis (MS), juvenile diabetes mellitus (JDM), and graft‐versus‐host disease (GVHD), in a manner enabling its translation into a clinical setting. Further investigation of this compound is warranted.Keywords
This publication has 38 references indexed in Scilit:
- Signaling between embryo and mother in early pregnancy: Basis for development of tolerance2007
- Uterine (CD56+) Natural Killer Cells Recruitment: Association with Decidual Reaction Rather than Embryo ImplantationAmerican Journal of Reproductive Immunology, 2006
- Pregnancy and rheumatoid arthritisIndian Journal of Medical Sciences, 2006
- Investigation of the immunocompetent cells that bind early pregnancy factor and preliminary studies of the early pregnancy factor target moleculeImmunology & Cell Biology, 2004
- Alloantigen recognition in utero: dual advantage for the fetus?Trends in Immunology, 2004
- Predominant expression of Th2 cytokines and interferon-γ in xenogeneic cardiac grafts undergoing acute vascular rejection1Transplantation, 2003
- Alterations in Th1/Th2 cytokine concentrations in early neonatal lifeThe Journal of Maternal-Fetal & Neonatal Medicine, 2003
- Development and Validation of an Assay for Measuring Preimplantation Factor (PIF) of Embryonal OriginAmerican Journal of Reproductive Immunology, 1996
- Preimplantation Factor (PIF) Predicts Subsequent Pregnancy LossAmerican Journal of Reproductive Immunology, 1995
- Use of Lymphocyte Platelet Binding Assay for Detecting a Preimplantation Factor: A Quantitative AssayAmerican Journal of Reproductive Immunology, 1994